CathVision Press Release 

COPENHAGEN, Denmark, April 21, 2025 -- CathVision, a leader in advanced cardiac electrophysiology (EP) technology, is pleased to announce its participation and exhibition at the Heart Rhythm Society (HRS) 2025 Annual Scientific Sessions at the San Diego Convention Center in San Diego, California. The premier scientific event in electrophysiology, scheduled from April 24^th – 27^th, 2025, will host global EP specialists, healthcare professionals, and industry leaders, showcasing groundbreaking research and innovative technologies shaping the future of cardiac care.

At HRS 2025, two significant achievements will be presented that highlight the capabilities of our state-of-the-art EP solutions:

• Thursday April 24^th 5.00-6.30pm PDT: Measurement of Unipolar Residual Signals Following Pulsed-Field Ablation (PFA), from Mt. Sinai Hospital (New York City), presented by Dr. Keita Watanabe.
• Friday April 25^th 3.30-5.30pm PDT: Detection of Electrically Silent Gaps Using a Unipolar Local Energy Algorithm in Pulsed-Field and RF Ablation, from OLV Aalst (Belgium), presented by Dr. Tom De Potter.

CathVision will seek to engage visitors in expert discussions and technology demonstrations at their booth (#1341), allowing attendees to explore innovative EP technologies. The CathVision team, including senior executives and clinical experts, will be present to discuss clinical applications, procedural efficiencies, and the promising impacts of their latest research findings.

"We're proud to introduce our latest scientific advancements at HRS 2025, reinforcing our commitment to transforming electrophysiological care," said Mads Matthiesen, CEO at CathVision. "Our emerging, cutting-edge algorithms and precise measurement techniques can help enhance clinicians' ability to optimize ablation outcomes, ultimately benefiting patients worldwide."

About CathVision

CathVision is a medical technology company dedicated to advancing cardiac electrophysiology through innovative solutions that deliver unmatched signal clarity and actionable insights during catheter ablation procedures through its ECGenius System. Combining artificial intelligence, advanced algorithms, and intuitive user interfaces in its CARDIALYTICS suite of modules, CathVision empowers clinicians to make more informed clinical decisions, leading to improved patient outcomes. Founded in 2013, CathVision is headquartered in Denmark, and its U.S. office is in Minnesota.

For more information, visit www.cathvision.com or follow CathVision on LinkedIn and Twitter. To meet directly with CathVision at HRS 2025, please visit booth #1341.